|
RAP2C expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.876200E-01 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.568400E-01 |
| Normal-vs-AfricanAmerican |
7.132800E-01 |
| Normal-vs-Asian |
1.873240E-01 |
| Caucasian-vs-AfricanAmerican |
2.127600E-01 |
| Caucasian-vs-Asian |
1.757230E-01 |
| AfricanAmerican-vs-Asian |
1.767710E-02 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.843600E-01 |
| Normal-vs-Female |
9.664800E-01 |
| Male-vs-Female |
7.704800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.112400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.153000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.291200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.205600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.468300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.620600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.203400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.198600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.756400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.732200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
6.295000E-01 |
| Normal-vs-Pheochromocytoma |
9.186200E-01 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
9.155000E-01 |
| Paraganglioma-vs-Pheochromocytoma |
6.053700E-02 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
5.047600E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
5.503000E-01 |
|
|
